Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShort-Term Debt repayments
Ratios

Cue Biopharma (CUE) Leases (2019 - 2025)

Cue Biopharma (CUE) has disclosed Leases for 7 consecutive years, with $4.1 million as the latest value for Q4 2025.

  • Quarterly Leases fell 6.77% to $4.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 million through Dec 2025, down 6.77% year-over-year, with the annual reading at $4.1 million for FY2025, 6.77% down from the prior year.
  • Leases hit $4.1 million in Q4 2025 for Cue Biopharma, down from $4.6 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $9.9 million in Q2 2022 to a low of $369000.0 in Q4 2022.
  • Historically, Leases has averaged $5.9 million across 5 years, with a median of $5.3 million in 2024.
  • Biggest five-year swings in Leases: plummeted 96.24% in 2022 and later soared 1613.55% in 2023.
  • Year by year, Leases stood at $9.8 million in 2021, then tumbled by 96.24% to $369000.0 in 2022, then skyrocketed by 1613.55% to $6.3 million in 2023, then tumbled by 30.89% to $4.4 million in 2024, then dropped by 6.77% to $4.1 million in 2025.
  • Business Quant data shows Leases for CUE at $4.1 million in Q4 2025, $4.6 million in Q3 2025, and $5.1 million in Q2 2025.